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Abstract
Objectives To prospectively investigate the pre and intra-
procedural risk factors for immediate (IF) and delayed-
onset (DOF) fever development after percutaneous tran-
shepatic biliary drainage (PTBD).
Methods Institutional review board approval and
informed patient consent were obtained. Between February
2013 and February 2014, 97 afebrile patients (77 at the
Sapienza University of Rome, Italy and 20 at the Sun Yat-
sen University of Guangzhou, China) with benign (n = 31)
and malignant (n = 66) indications for a first PTBD were
prospectively enrolled. Thirty pre- and intra-procedural
clinical/radiological characteristics, including the amount
of contrast media injected prior to PTBD placement, were
collected in relation to the development of IF (within 24 h)
or DOF (after 24 h). Fever was defined as C37.5 C.
Binary logistic regression analysis was used to assess
independent associations with IF and DOF.
Results Fourteen (14.4 %) patients developed IF and 17
(17.5 %) developed DOF. At multivariable analysis, IF
was associated with pre-procedural absence of intrahepatic
bile duct dilatation (OR 63.359; 95 % CI 2.658–1510.055;
P = 0.010) and low INR (OR 4.7 9 10-4; 95 % CI
0.000–0.376; P = 0.025), while DOF was associated with
unsatisfactory biliary drainage at the end of PTBD (OR
4.571; 95 % CI 1.161–17.992; P = 0.030).
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Conclusions The amount of contrast injected is not
associated with post-PTBD fever development. Unsatis-
factory biliary drainage at the end of PTBD is associated
with DOF, suggesting that complete biliary tree decom-
pression should be pursued within the first PTBD. Patients
with unsatisfactory drainage and those with the absence of
pre-procedural intrahepatic bile duct dilatation, which is
associated with IF, require tailored post-PTBD
management.
Keywords Percutaneous transhepatic biliary
drainage  Fever  Unsatisfactory biliary drainage 
Bile duct dilatation  Contrast media volume
Abbreviations
PTBD Percutaneous transhepatic biliary drainage
IR Interventional radiology
IF Immediate fever
DOF Delayed-onset fever
ERCP Endoscopic retrograde cholangiopancreatography
CT Computed tomography
MR Magnetic resonance
AST Aspartate aminotransferase
ALT Alanine aminotransferase
ALP Alkaline phosphatase
GGT Gamma glutamyl transpeptidase
WBC White blood cell
INR Prothrombin time
ECG Electrocardiography
SpO2 Oxygen saturation
NIBP Non-invasive blood pressure
Introduction
Interventional radiological percutaneous approach to bil-
iary procedures has been codified as second-line treatment,
in both benign and malignant settings, after failed or
technically unfeasible retrograde endoscopic approach [1,
2]. Thus, thanks to the achievement of technical improve-
ments, the percutaneous transhepatic biliary drainage
(PTBD) procedure is nowadays performed in patients with
either a history of jaundice [3–10] or with the need for
urgent treatment of a biliary leakage [11, 12].
Cholangitis is a frequent cause of post-procedural fever
development. However, in patients treated with PTBD,
there is poor agreement on the definition of cholangitis,
when it is not severe and is not associated to sepsis. In fact,
different definitions have been used in terms of minimal
cut-off value of body temperature elevation and fever
onset, fever duration, cut-off values for its severity,
associated signs (i.e., increase in white blood cell count),
and clinical-associated characteristics. [3, 4, 6, 7, 9]
In addition, fever development after PTBD, even if not
due to cholangitis, is a possible reason of prolonged hos-
pitalization and changing clinical management.
Knowledge of the pre-PTBD or procedural-related risk
factors for the development of fever would be useful to
identify the best post-procedural patient care strategies and
procedural technical modifications. Among the latter,
limiting the amount of contrast media injected during
cholangiography prior to PTBD is currently advised [13,
14], based on the experimental evidence that, in the
infected bile duct-ligated cholestatic dog model, endotox-
inemia occurs secondary to regurgitation via cholangio-
venous reflux [15, 16].
The aim of this study was to prospectively investigate
the risk factors for post-procedural immediate and delayed-
onset fever among pre- intra-procedural clinical, radio-
logical imaging, and laboratory characteristics, in patient
undergoing PTBD for both benign and malignant
indications.
Materials and Methods
This study was approved by the institutional review board
of the Radiology Department at the Sapienza University of
Rome, Italy and of the Vascular Interventional Radiology
Department at the 3rd affiliated Hospital of Sun Yat-sen
University in Guangzhou, China and followed the princi-
ples of the Declaration of Helsinki and subsequent
amendments [17]. All patients provided written informed
consent. Between February 2013 and February 2014, a total
of 127 first PTBD were performed in two tertiary referral
centers (98 at the Italian Center and 29 at the Chinese
Center). We prospectively enrolled all patients without
fever defined as axillary temperature\37.5 C, during the
previous week and without extrahepatic active infections.
Thirty patients were excluded: 16 because of fever during
the week prior to the procedure, 10 patients with indwel-
ling stents from prior endoscopic procedures, 1 HIV-posi-
tive subject, and 3 patients because of other extrahepatic
infections (2 pneumonia, 1 urinary infection). Thus, the
study comprised 97 (77 at the Italian Center and 20 at the
Chinese Center) patients with benign (n = 31, 32 %) and
malignant (n = 66, 68 %) indications.
Pre- and intra-procedural clinical, radiological imaging,
and laboratory characteristics were investigated in order to
stratify the risk of onset of post-procedural immediate (IF)
or delayed-onset fever (DOF) and to evaluate their poten-
tial association with these clinical events. All patients were
hospitalized for at least 10 days after PTBD or until death
and evaluated for axillary body temperature every 8 h or in
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the presence of clinical suspicion of fever. IF and DOF
were defined as fever (C37.5 C) that arose within or after
24 h until 10 days from the procedure, respectively. Fever
in the IF group could have continued after 24 h or not,
according to treatment response. However, all patients with
IF were not included in the DOF group.
Clinical risk factors assessed were the presence of
ascites, diabetes, recurrent previous cholangitis, and pre-
vious interventions on the biliary system [biliary anasto-
mosis, endoscopic retrograde cholangiopancreatography
(ERCP), sphincterotomy, cholecystectomy], previous
oncological history.
Pre-procedural radiological imaging parameters asses-
sed with computed tomography (CT) or magnetic reso-
nance (MR) were diameter of the right, left, and main
biliary ducts, the presence or absence of intrahepatic bile
duct dilatation. Non-dilated peripheral bile ducts were
defined as those measuring\2 mm in diameter or smaller
than the closest portal vein [18]. In the absence of intra-
hepatic bile duct dilatation PTBD was performed in the
presence of persisting bile leak untreatable with ERCP.
Intra-procedural variables recorded were injected volume
of contrast media during cholangiography prior to biliary
drainage placement, PTBD duration, and complete (when
all liver segments were drained) or incomplete (when one
or more liver segments were not drained) biliary drainage
at the end of the procedure.
Pre-procedural (immediately before) and post-procedu-
ral (36–48 h) laboratory values were serum total and con-
jugated bilirubin, aspartate aminotransferase (AST),
alanine aminotransferase (ALT), alkaline phosphatase
(ALP), gamma glutamyl transpeptidase (GGT), and albu-
min. Prothrombin time (INR) and blood cell counts were
also measured.
All procedures were performed by one of three inter-
ventional radiologists (P.L., M.C. and H.W. with 8, 20, and
9 years of experience in biliary procedures, respectively) in
cFig. 1 Two-step PTBD technique. Seventy-one-year-old female
jaundiced (direct bilirubin 7 mg/dl) patient, whom endoscopic
(ERCP) procedure failed for main biliary duct stenosis. Panel A
Postero-anterior X-ray. Percutaneous cholangiography, performed via
a 22-G Chiba needle, demonstrated dilated intrahepatic biliary ducts
due to hilar obstruction. Panel B Postero-anterior X-ray. Based on
percutaneous cholangiography, segment VI duct was selected as the
best peripheral duct to be accessed for PTBD and punctured with a
5-Fr cannula needle, allowing engagement of the stenosis with
hydrophilic standard wire (Terumo, Tokyo, JPN). Panel C Postero-
anterior X-ray. Once the duodenum was gained, dilatation of the tract
and trans-papillary positioning of the biliary drainage (10 Fr) was
performed
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a dedicated angio-suite (Artis Zee, Erlangen, Germany for
both Italian and Chinese Center), under antibiotic pro-
phylaxis with intravenous cefotaxime (1 gr before the
procedure on the same day). Figures 1 and 2 show the
procedure in the presence of dilated and non-dilated
intrahepatic biliary tree, respectively. All procedures were
categorized as satisfactory or unsatisfactory whether the
biliary tree was completely or incompletely drained.
Incomplete drainage was defined as either ducts which
were not opacified by contrast medium during PTC
because of complete obstruction or stenotic opacified ducts
which were not drained.
Primary end point of the study was to evaluate the
association between pre- and intra-procedural variables
with IF and DOF. Secondary end point was to evaluate
post-procedural laboratory value changes according to
fever occurrence and its timing.
Statistical Analysis
Power analysis indicated that a total number of at least 95
patients were needed considering an expected prevalence
of 15 % of immediate post-procedural fever, type I error
rate/a of 0.20, and type II error rate/b of 0.05.
The normality of each continuous variable group was
tested using the Kolmogorov–Smirnov Z test. Data were
described as the median value (25th–75th percentiles) or as
number (percentage) for continuous and categorical vari-
ables, respectively. Intergroup comparisons of pre- and
intra-procedural variables according to the occurrence of IF
or DOF, compared to the no fever group, were done using
the Mann–Whitney test and the X2 or the Fisher text for
parametric and non-parametric variables, respectively.
Binary logistic regression analysis was then calculated
for the IF and DOF to identify the independent associations
of different parameters with fever, including all variables
with a P value B 0.150 at univariable analyses. A
P value\ 0.05 was regarded to indicate statistical signif-
icance. Statistical analyses were performed with the sta-
tistical package for social science (SPSS 18.1; USA).
Results
Clinical and Radiological Features of the Entire
Population Before and at PTBD
Table 1 shows the clinical and radiological features of the
entire study population before and at PTBD.
The indication for PTBD was malignant and benign in
68 and 32 % of cases, respectively. No intrahepatic abscess
was present in any patient. In 10.3 % of cases, the
procedure was performed in the absence of intrahepatic
bile duct dilatation.
Because of the involvement of bile ducts by malignancy,
measurement of the main, left, and right bile duct diameter
was not applicable in 32, 8, and 11 cases, respectively. The
internal–external trans-papillary catheter positioning was
achieved in all cases and PTDB was classified as satis-
factory in 74.2 % of cases.
Fourteen (14.4 %) patients developed fever within the
first 24 h from the PTBD procedure and 17 patients
Fig. 2 Two-step PTBD technique in non-dilated biliary tree. Sixty-
six-year-old female patient treated with duodeno-cephalo-pancreate-
ctomy for pancreas carcinoma, who presented with a biliary leak from
the surgical drainage. Panel A Postero-anterior X-ray. Percutaneous
cholangiography, performed via a 22-G Chiba needle, demonstrated
non-dilated intrahepatic biliary ducts with a biliary anastomosis leak.
Panel B Postero-anterior X-ray. Once the bowel loop was gained,
dilatation of the tract and trans-papillary positioning of the biliary
drainage (10 Fr) was performed
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Table 1 Clinical and
radiological features of the
entire study population before
and at PTBD
Demographics
Age (years) 64.00 (57.00–73.50)
Gender n (%)
Male 62 (63.9)
Female 35 (36.1)
Center n (%)
Rome, Italy 77 (79)
Guangzhou, China 20 (21)
Clinical features
Cause of cholestasis n (%)
Benign 31 (32.0)
Biliary tree stones 10 (10.3)
Iatrogenic biliary three stenosis 12 (12.4)
Iatrogenic biliary tree leak 5 (5.2)
Bilio-digestive anastomosis stenosis 3 (3.1)
Necrotizing pancreatitis 1 (1.0)
Malignant 66 (68.0)
Pancreatic cancer 17 (17.5)
Hilar cholangiocarcinoma 32 (33.0)
Distal cholangiocarcinoma 1 (1.0)
Gallbladder cancer 2 (2.1)
Gastric cancer lymphadenopathy 7 (7.2)
Liver metastasis 6 (6.2)
Serum total bilirubin (mg/dl) 10.60 (72.90–21.08)
Serum conjugated bilirubin (mg/dl) 9.05 (2.20–17.86)
Serum alkaline phosphatase (IU/L) 418.50 (226.50–641.50)
Serum gamma-glutamyltransferase (IU/L) 368.00 (189.50–681.50)
Serum ALT (IU/L) 80.00 (39.00–153.50)
Serum AST (IU/L) 76.00 (49.00–129.00)
White blood cell count (cells x 103/ll) 7.02 (5.37–9.41)
Neutrophil blood count (cells 9 103/ll) 5.10 (3.30–7.18)
Neutrophil blood count (% of white blood cells) 72.00 (62.25–81.35)
Platelet blood count (cells 9 103/ll) 214.00 (158.00–294.00)
INR 1.10 (1.02–1.20)
Serum albumin (mg/dL) 34.00 (28.50–38.00)
Presence of ascites, n (%) 16 (16.5)
Presence of diabetes, n (%) 8 (8.2)
Recurrent previous cholangitis, n (%) 12 (12.4)
Previous ERCP, n (%) 44 (45.4)
Previous sphincterotomy, n (%) 19 (19.6)
Previous cholecystectomy, n (%) 15 (15.5)
Previous bilio-digestive anastomosis 20 (20.6)
Radiological features before and during PTBD
Main bile duct diameter (mm)a 11.00 (6.00–15.00)
Left bile duct diameter (mm)b 11.00 (8.00–13.20)
Right bile duct diameter (mm)c 10.00 (7.00–13.00)
Absence of intrahepatic bile duct dilatation, n (%) 10 (10.3)
Volume of contrast media injected (ml) 36.00 (22.00–42.00)
PTBD duration (min) 45.00 (35.00–75.00)
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(17.5 %) after the first 24 h. In 66 patients, no fever
occurred during the first 10 days after PTBD.
One patient (1.03 %) affected by an obstructive jaundice
due to pancreatic cancer experienced fever, chills, and
hemodynamic instability within the first 24 h after the
procedure, consistent with septic shock. This patient died
despite hemodynamic support and resuscitation protocol.
Clinical and Radiological Features Before
and at PTBD According to Subsequent Development
of Fever
Table 2 shows the clinical and radiological features before
and at PTBD in patients without fever and in the IF and
DOF groups. At univariable analyses, the IF group, com-
pared to patients without fever, showed significantly lower
age, more frequently had a previous bilio-digestive anas-
tomosis and the absence of intrahepatic bile duct dilatation.
In particular, 5 out of 10 patients without intrahepatic bile
duct dilatation developed IF. Among the 5 patients without
intrahepatic bile duct dilatation and subsequent IF, the
indication to perform PTBD was a biliary leak (n = 4) and
a necrotizing pancreatitis (n = 1). In patients with a biliary
leak, no extrahepatic bile collections were seen at pre-
procedural CT or MR. At multivariable analysis, the
absence of intrahepatic bile duct dilatation (OR 63.359;
95 % CI 2.658–1510.055; P = 0.010) and low INR (OR
4.7 9 10-4; 95 % CI 0.000–0.376; P = 0.025) were sig-
nificantly associated with IF (Table 3).
At univariable analyses, the DOF group, compared to
patients without fever, showed significantly more frequent
previous cholecystectomy and unsatisfactory biliary drai-
nage after PTBD (Table 2). At multivariable analysis, only
unsatisfactory biliary drainage at the end of PTBD (OR
4.571; 95 % CI 1.161–17.992; P = 0.030) was signifi-
cantly associated with DOF (Table 4).
Changes of Laboratory Values After PTBD
According to Subsequent Development of Fever
Supplementary Table 1 shows all the laboratory values
before and after PTBD in patients without fever and in the
IF and DOF groups.
Figure 3 shows the box plots of serum conjugated
bilirubin concentration and white blood cells count before
and after PTBD in the three study groups. Changes of
serum conjugated bilirubin values included (median [25th
percentile-75th percentile]): a decrease [12.56 (2.12–19.63)
vs 8.64 (1.62-15.68), before and after PTBD, respectively;
P\ 0.001) in the no fever group; a decrease [7.03
(2.33–11.96) vs 4.68 (2.34–8.33), before and after PTBD,
respectively; P = 0.008) in the IF group. However, no
significant difference [7.94 (4.63–12.03) vs 8.43
(2.96–12.03), before and after PTBD, respectively;
P = 0.196) was found in the DOF group.
Changes of white blood cells count values included
(median [25th percentile–75th percentile]): an increase
[7.03 (5.22–9.46) vs 8.18 (6.05–11.27), before and after
PTBD, respectively; P\ 0.001) in the no fever group; an
increase [6.95 (5.96–7.91) vs 10.40 (8.68–13.22), before
and after PTBD, respectively; P\ 0.001) in the DOF
group. However, no significant difference [6.98
(6.27–12.20) vs 6.96 (5.31–9.51), before and after PTBD,
respectively; P = 0.480) was found in the IF group.
Discussion
The main results of our prospective study are that pre-
procedural factors independently associated with IF are the
absence of intrahepatic bile duct dilatation and low INR,
while DOF is associated to unsatisfactory biliary drainage
after PTBD.
Lower INR values as a factor associated with IF prob-
ably reflects the operator confidence to perform the pro-
cedure even when technically challenging, because of the
relatively preserved blood clotting system. Two hypotheses
could explain the association of the non-dilated intrahep-
atic biliary tree with IF. First, although we did not find any
difference in the procedure duration between the IF and the
group without fever, the non-dilated biliary tree could
reflect a higher technical complexity of the procedure
compared to those performed on a dilated biliary system,
associated with a higher chance of mechanical traumatism
inducing local inflammation. The second, possibly coex-
isting, explanation is that the indication to perform PTDB
Table 1 continued Radiological features after PTBD
Unsatisfactory biliary tree drainage 25 (25.8)
Data are reported as medians (25th–75th percentile) for continuous variables. Absolute and relative fre-
quencies are reported for categorical ones
PTBD percutaneous transhepatic biliary drainage
a Measurement available in 65 cases
b Measurement available in 89 cases
c Measurement available in 86 cases
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Table 2 Univariable analysis of clinical and radiological features before and at PTBD according to subsequent development of fever
No fever (n = 66) IF (n = 14) DOF (n = 17) P value*
(IF)
P value**
(DOF)
Demographics
Age (years) 66.00 (58.00–75.00) 57.50 (51.25–65.50) 66.00 (57.50–74.00) 0.023 0.941
Gender, n (%) 0.760 0.844
Male 41 (62.1) 10 (71.4) 11 (64.7)
Female 25 (37.9) 4 (28.6) 6 (35.3)
Center, n (%) 0.064 0.281
Rome, Italy 53 (80.3) 8 (57.1) 16 (94.1)
Guangzhou, China 13 (19.7) 6 (42.9) 1 (5.9)
Clinical features
Cause of cholestasis, n (%) 0.362 1.000
Benign 20 (30.3) 6 (42.9) 5 (29.4)
Malignant 46 (69.7) 8 (57.1) 12 (70.6)
Serum total bilirubin (mg/dl) 14.36 (2.99–23.17) 7.69 (1.46–13.96) 9.25 (3.39–14.46) 0.349 0.297
Serum conjugated bilirubin (mg/dl) 12.55 (2.28–19.49) 7.03 (1.46–12.44) 7.92 (2.93–11.82) 0.293 0.349
Serum alkaline phosphatase (IU/L) 415.00
(231.50–657.00)
329.00
(157.50–525.50)
479.00
(241.50–674.00)
0.168 0.693
Serum gamma-glutamyltransferase (IU/L) 368.00
(189.50–676.75)
407.00
(177.15–628.50)
307.00
(198.50–1012.50)
0.995 0.787
Serum ALT (IU/L) 86.50
(42.75–170.25)
77.50 (31.25–122.50) 74.00 (36.50–170.00) 0.365 0.991
Serum AST (IU/L) 73.50
(50.75–140.25)
80.00 (25.00–116.50) 78.00 (50.00–155.00) 0.518 0.813
White blood cell count (cells 9 103/ll) 7.03 (5.16–9.48) 7.03 (6.46–12.30) 6.88 (5.85–7.81) 0.212 0.608
Neutrophil blood count (cells 9 103/ll) 4.96 (3.15–7.27) 5.47 (3.70–9.33) 5.00 (3.40–5.80) 0.264 0.537
Neutrophil blood count (% of white blood
cells)
71.25 (61.25–81.28) 75.07 (66.70–83.70) 74.10 (61.60–78.95) 0.455 0.821
Platelet blood count (cells 9 103/ll) 215.00
(159.75–293.00)
202.50
(146.75–298.25)
214.00
(174.50–296.50)
0.756 0.977
INR 1.10 (1.02–1.21) 1.06 (0.94–1.13) 1.06 (1.02–1.17) 0.114 0.668
Serum albumin (mg/dL) 34.00 (28.00–38.00) 34.95 (30.50–44.00) 33.00 (27.00–39.00) 0.617 0.977
Presence of ascites, n (%) 9 (13.6) 5 (35.7) 2 (11.8) 0.063 1.000
Presence of diabetes, n (%) 4 (6.1) 1 (7.1) 3 (17.6) 1.000 0.148
Recurrent previous cholangitis, n (%) 9 (13.6) 0 (0) 3 (17.6) 0.348 0.704
Previous ERCP, n (%) 29 (43.9) 4 (28.6) 11 (64.7) 0.376 0.127
Previous sphincterotomy, n (%) 11 (16.7) 3 (21.4) 5 (29.4) 0.703 0.301
Previous cholecystectomy, n (%) 9 (13.6) 0 (0) 6 (35.3) 0.348 0.039
Previous bilio-digestive anastomosis 11 (16.7) 6 (42.9) 3 (17.6) 0.030 1.000
Radiological features before and during PTBD
Main bile duct diameter (mm)a 10.50 (6.25–14.75) 6.00 (4.00–15.00) 15.00 (11.25–17.45) 0.140 0.162
Left bile duct diameter (mm)b 11.00 (9.00–13.88) 11.00 (5.43–17.20) 8.50 (7.00–11.00) 0.696 0.076
Right bile duct diameter (mm)c 10.00 (8.00–12.00) 8.85 (5.00–14.75) 8.50 (7.00–13.00) 0.693 0.475
Absence of intrahepatic bile duct dilatation,
n (%)
5 (7.6) 5 (35.7) 0 (0) 0.012 0.578
Volume of contrast media injected (ml) 35.00 (22.00–42.25) 35.50 (19.75–42.75) 41.00 (28.00–43.50) 0.970 0.124
PTBD duration (min) 45.00 (35.00–73.00) 60.50 (36.25–88.75) 60.00 (35.00–90.00) 0.880 0.202
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could represent per se the cause of fever, due to an unin-
fected mild peritonitis, even in the absence of extrahepatic
bile collections at pre-procedural CT or MR. In fact, out of
a total of 10 patients with non-dilated intrahepatic biliary
tree, the indication to the procedure for the 5 with IF was a
condition associated with choleperitoneum secondary to a
biliary leak (n = 4) and with a necrotizing pancreatitis
(n = 1). Ahn et al. recently found that INR was not an
associated factor to the development of immediate fever
after PTBD, while intrahepatic biliary dilatation was not
evaluated since they enrolled only patients with a malig-
nant indication for PTBD [3]. The absence of intrahepatic
bile duct dilatation was not found to be associated with
fever after PTBD at univariable analysis by Weber et al.
[6]. However, in Weber’ s study, the timing of fever onset
is not reported and the threshold to identify patients with
fever was very conservative, considering only patients with
at least 38.5 C lasting for more than 24 h.
The second main result of our present study is that
unsatisfactory biliary drainage after PTBD was the only
factor independently associated with DOF. Unsatisfactory
biliary drainage after PTBD has already been shown to be
associated with late-onset cholangitis at univariable anal-
ysis [9]. In addition, it is known that the occurrence of
Table 2 continued
No fever (n = 66) IF (n = 14) DOF (n = 17) P value*
(IF)
P value**
(DOF)
Radiological features after PTBD
Unsatisfactory biliary tree drainage 13 (19.7) 3 (21.4) 9 (52.9) 1.000 0.006
Data are reported as medians (25th–75th percentile) for continuous variables. Absolute and relative frequencies are reported for categorical ones.
Differences between groups were tested with an independent t test or Mann-Whitney U test according to the distribution of the value for
continuous variables and with chi-square test for categorical ones
Bold values represent variables that express a statistical significance: P value B 0.150 at univariable analyses
PTBD percutaneous transhepatic biliary drainage; IF immediate fever; DOF delayed-onset fever
* P value non-fever versus IF
** P value non fever versus DOF
a Measurement available in 65 cases
b Measurement available in 89 cases
c Measurement available in 86 cases
Table 3 Multivariable analyses
for predictors of Immediate
Fever (IF)
OR CI P value
Age (years) 1.065 0.957–1.185 0.251
Center (Rome vs Guangzhou) 0.156 0.010–2.447 0.186
INR 4.7 9 10-4 0.000–0.376 0.025
Presence of ascites 4.207 0.435–40.657 0.215
Previous bilio-digestive anastomosis 0.845 0.108–6.604 0.872
Main bile duct diameter (mm) 0.989 0.846–1.156 0.886
Absence of intrahepatic bile duct dilatation 63.359 2.658–1510.055 0.010
Bold values represent variables that express a statistical significance: P value\ 0.05 at multivariable
analyses
Table 4 Multivariable analyses
for predictors of delayed-onset
fever (DOF)
OR CI P value
Presence of diabetes 4.791 0.655–35.063 0.123
Previous ERCP 3.696 0.887–15.400 0.073
Previous cholecystectomy 1.783 0.404–7.863 0.445
Left bile duct diameter (mm) 0.809 0.653–1.002 0.052
Volume of contrast media injected (ml) 1.019 0.982–1.058 0.320
Unsatisfactory biliary tree drainage 4.571 1.161–17.992 0.030
Bold values represent variables that express a statistical significance: P value\ 0.05 at multivariable
analyses
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biliary tree bacterial colonization after PTBD is common
[5, 9] involving up to 25 % of cases initially non-infected
after 24 h from the procedure [8]. It is likely that, leaving
one or more hepatic segments undrained, facilitates bac-
terial growth and development of fever. The latter
hypothesis is in keeping with our present data showing that
in the DOF cohort, but not in patients without fever and in
those with IF, serum conjugated bilirubin concentration did
not decrease after PTBD. All this considerations suggest
that the operator should try to obtain jaundice relief within
the first session in order to keep at the minimum the chance
of DOF.
Different values of the minimum cut-off level for fever
definition have been reported ranging from 37.5 [19, 20]
and 38.3 C [21]. Since axillary temperature is about
0.55 C less than the oral temperature [20], in the present
study, we used an axillary temperature cut-off of C37.5 C
to define IF and DOF. Our prospective protocol, with at
least 10 days of hospitalization, did not allow to assess the
relationships between the post-PTBD fever and length of
hospital stay. However, the relevance of our findings on
risk factors for post-PTBD fever is that they allow to
identify patients in whom hospitalization is likely to be
prolonged, needing strict post-procedural monitoring (i.e.,
Fig. 3 Box plots of serum
conjugated bilirubin and
neutrophil blood count before
and after PTBD in patients who
did not experience fever and in
the immediate (IF) and delayed-
onset (DOF) fever groups.
*P\ 0.01; **P\ 0.001
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fever measurement, scheduled blood cultures) and eventual
adjunctive antibiotic treatment.
Although the amount of contrast media injected has
been usually considered as a risk factor for post-PTBD
cholangitis and sepsis based on animal models [15, 16], in
our study, the amount of contrast injected prior to PTBD
was not associated to IF or DOF, suggesting that it should
not be considered a limitation to perform challenging bil-
iary procedures.
The main limitations of our study are the lack of bilio-
cultures prior to biliary drainage positioning and the lack of
registration of bile duct number of punctures. In addition,
we did not separately analyze, as a risk factor for fever,
incomplete drainage of non-opacified obstructed ducts and
that of stenotic opacified ducts as did Chang et al. [22].
Finally, the potential bias due to the multicenter charac-
teristic of the study and the relatively low number of
patients with a non-dilated biliary tree are likely to be
minimized by the strict prospective study protocol,
including these variables in the multivariable analyses.
In summary, our present study demonstrates that the pre-
procedural absence of intrahepatic bile duct dilatation and
low INR are independently associated with IF. These
findings probably reflect the operator confidence to perform
the procedure even when technically challenging. The
second evidence is that unsatisfactory biliary drainage at
the end of PTBD is the only factor independently associ-
ated with the development of DOF. These data are relevant
to identify patients in whom strict post-procedural moni-
toring and eventual adjunctive antibiotic treatment should
be performed. In addition, major efforts should be pursued
to obtain complete biliary tree decompression within the
first PTBD.
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